TITLE

Low dose oral methotrexate treatment of multiple sclerosis: a pilot study

AUTHOR(S)
Currier, R D; Haerer, A F; Meydrech, E F
PUB. DATE
November 1993
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Nov1993, Vol. 56 Issue 11, p1217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66121786

 

Related Articles

  • Investigative Dermatology.  // Current Medical Literature: Dermatology;2007, Vol. 12 Issue 2, p39 

    The article presents abstracts of medical research. They include "Evaluation of oral methotrexate in the treatment of systemic sclerosis," "An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema," and "Maternal testosterone in pregnancy and atopic outcomes...

  • Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.  // Trials;2012, Vol. 13 Issue 1, p15 

    The article focuses on an interventional clinical phase II trial conducted to test the safety of high-dose vitamin D supplementation for multiple sclerosis patients and its superiority to low-dose supplementation regarding to beneficial therapeutic effects. In the pilot study eighty patients who...

  • Oral effects of low-dose methotrexate treatment. Watts, Trevor // British Dental Journal;10/8/2005, Vol. 199 Issue 7, p437 

    Presents the abstract of the article "Oral Effects of Low-Dose Methotrexate Treatment," by A. Kalantzis and Z. Marshman.

  • Low-dose naltrexone improves QOL in MS.  // PharmacoEconomics & Outcomes News;9/18/2010, Issue 612, p11 

    The article discusses research on the use of low-dose naltrexone to improve quality of life (QOL) of patients suffering from multiple sclerosis (MS), which references the study "Pilot Trial of Low-Dose Naltrexone and Quality of Life in Multiple Sclerosis," by B. A. Cree et al.

  • Evaluation of the role of erythropoietin and methotrexate in multiple sclerosis. Dasgupta, Sandipan; Mazumder, Bhaskar; Roja Ramani, Y.; Bhattacharyya, Subhra Prakash; Das, Mukesh K. // Indian Journal of Pharmacology;Oct2011, Vol. 43 Issue 5, p512 

    Background: Erythropoietin, originally recognized for its role in erythropoiesis, has been shown to improve neurological outcome after stroke. Low-dose methotrexate is effective against certain inflammatory diseases, such as severe psoriasis and rheumatoid arthritis as well as Crohn's disease....

  • Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial. Ashtari, Fereshteh; Reza Savoj, Mohammad // Journal of Research in Medical Sciences;Apr2011, Vol. 16 Issue 4, p457 

    BACKGROUND: Methotrexate, a toxic antimetabolite that limits cellular reproduction by acting as an antagonist to folic acid, has been used to control autoimmune disease with different results. The aim of this study was to evaluate the effectiveness of low dose Methotrexate in the...

  • Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. Solaro, Claudio; Boehmker, Margit; Tanganelli, Paolo // Journal of Neurology;Oct2009, Vol. 256 Issue 10, p1773 

    A letter to the editor is presented which focuses on a pilot study of pregabalin for the treatment of paroxysmal painful symptoms in multiple sclerosis.

  • Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice. Mueller, Andre Michael; Nassery, Adam; Conlon, Hana; Xinhe Liu; Jun, Esther; Bo Hyung Yoon; Cristofanili, Massimiliano; Saud Ahmed Sadiq // Frontiers in Molecular Neuroscience;Sep2013, Vol. 6, p1 

    We previously showed that intrathecal administration of methotrexate slowed disability progression in multiple sclerosis patients with progressive disease. In general MS patients with progressive disease respond poorly to anti-inflammatory therapies. In order to better understand the mechanism...

  • Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice. Mueller, Andre M.; Nassery, Adam; Conlon, Hana; Xinhe Liu; Jun, Esther; Bo Hyung Yoon; Cristofanilli, Massimiliano; Sadiq, Saud A. // Frontiers in Molecular Neuroscience;Oct2013, Vol. 6, p1 

    We previously showed that intrathecal administration of methotrexate slowed disability progression in multiple sclerosis (MS) patients with progressive disease. In general MS patients with progressive disease respond poorly to anti-inflammatory therapies. In order to better understand the...

  • Safety and efficacy of systemic psoriasis treatment. MATUSHEVSKAYA, E. V.; SVIRSHCHEVSKAYA, E. V.; MATUSHEVSKAYA, YU. I. // Klinicheskaya Dermatologia I Venerologia;2014, Issue 2, p4 

    The article presents results of Russian and foreign clinical studies on the efficacy and safety of methotrexate in systemic treatment of autoimmune diseases. The problems associated with control over methotrexate toxicity in treatment of severe psoriasis are considered. The need for folate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics